From CNN:
The U.S. Food and Drug Administration Monday advised doctors and patients about the possibility of severe and sometimes incapacitating bone, joint or muscle pain linked to popular drugs used to treat osteoporosis and other bone-thinning diseases.
Although a discussion of severe musculoskeletal pain is included in the prescribing information for all of the drugs, the agency said, "the association between bisphosphonates and severe musculoskeletal pain may be overlooked by healthcare professionals."
The drugs - sold under several brand names including Fosamax, by Merck & Co.; Boniva, by Roche Holding AG; Zometa and Reclast, by Novartis AG; and Actonel, by Procter and Gamble Co. - are known as bisphosphonates. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment